We utilized a siRNA to knockdown CDK4 in NSCLC cell lines, and the results showed a high knockdown efficiency of CDK4 in H1299 and A549 cells at the protein level (Figure 6B). The gene discussed is CDK4; the disease is non-small cell lung carcinoma.